Detalles de la búsqueda
1.
Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
Neurobiol Dis
; 187: 106287, 2023 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704058
2.
The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
J Neurochem
; 156(6): 715-752, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616931
3.
Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Neurobiol Dis
; 106: 133-146, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28673739
4.
Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.
Neurobiol Dis
; 71: 334-44, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25171793
5.
Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146].
Neurobiol Dis
; 116: 180, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29571591
6.
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.
FASEB J
; 26(5): 2154-63, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22345403
7.
LTP in hippocampal neurons is associated with a CaMKII-mediated increase in GluA1 surface expression.
J Neurochem
; 116(4): 530-43, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21143596
8.
Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
Neurobiol Dis
; 41(3): 591-604, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20971190
9.
Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses.
J Neurochem
; 112(3): 677-90, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19895665
10.
The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage.
PeerJ
; 5: e3933, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29062606
11.
Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.
J Vis Exp
; (60)2012 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22370630
12.
Generation of a model of L-DOPA-induced dyskinesia in two different mouse strains.
J Neurosci Methods
; 197(2): 193-208, 2011 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21352853
13.
Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
Mov Disord
; 17(3): 455-66, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12112191
14.
Interaction of SAP97 with minus-end-directed actin motor myosin VI. Implications for AMPA receptor trafficking.
J Biol Chem
; 277(34): 30928-34, 2002 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-12050163
15.
To serve and protect? Interventions in the subthalamic nucleus for Parkinson's disease. Commentary on "Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease".
Exp Neurol
; 185(2): 201-3, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14736500
Resultados
1 -
15
de 15
1
Próxima >
>>